8-fluoro-2-(2-methoxy-4-(4-methylpiperazin-1-yl)phenylamino)-5H-benzo[d]pyrimido[4,5-f][1,3]diazepin-6(7H)-one

ID: ALA4761820

PubChem CID: 162660766

Max Phase: Preclinical

Molecular Formula: C23H24FN7O2

Molecular Weight: 449.49

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  COc1cc(N2CCN(C)CC2)ccc1Nc1ncc2c(n1)-c1cccc(F)c1NC(=O)N2

Standard InChI:  InChI=1S/C23H24FN7O2/c1-30-8-10-31(11-9-30)14-6-7-17(19(12-14)33-2)26-22-25-13-18-21(28-22)15-4-3-5-16(24)20(15)29-23(32)27-18/h3-7,12-13H,8-11H2,1-2H3,(H,25,26,28)(H2,27,29,32)

Standard InChI Key:  JBWUCHLNYVBLTG-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 33 37  0  0  0  0  0  0  0  0999 V2000
   37.6307  -13.5992    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   37.6295  -14.4187    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   38.3376  -14.8277    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   38.3358  -13.1903    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   39.0474  -14.4196    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   39.0444  -13.5956    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   39.6894  -13.0736    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   40.4972  -13.2488    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   40.8587  -13.9923    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   40.5065  -14.7426    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   39.7013  -14.9304    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   39.4628  -15.7200    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   40.0285  -16.3226    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   40.8358  -16.1302    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   41.0705  -15.3409    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   41.0021  -12.6062    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   36.9215  -14.8268    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   36.9208  -15.6439    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.2127  -16.0504    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.2117  -16.8669    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.9196  -17.2768    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.6300  -16.8644    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.6275  -16.0493    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.5057  -15.6405    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   34.7973  -16.0478    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.9201  -18.0940    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   36.2099  -18.4997    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.2084  -19.3134    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.9145  -19.7254    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   37.6238  -19.3177    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.6270  -18.4979    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.9119  -20.5426    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   41.8655  -15.1518    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  5  2  0
  6  4  2  0
  4  1  1  0
  5  6  1  0
  6  7  1  0
  5 11  1  0
  7  8  1  0
  8  9  1  0
 10  9  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 10  1  0
  8 16  2  0
  2 17  1  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 23 18  1  0
 19 24  1  0
 24 25  1  0
 21 26  1  0
 26 27  1  0
 26 31  1  0
 27 28  1  0
 28 29  1  0
 29 30  1  0
 30 31  1  0
 29 32  1  0
 15 33  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4761820

    ---

Associated Targets(Human)

TNK2 Tclin Tyrosine kinase non-receptor protein 2 (2836 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

BaF3 (4657 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 449.49Molecular Weight (Monoisotopic): 449.1976AlogP: 3.74#Rotatable Bonds: 4
Polar Surface Area: 94.65Molecular Species: NEUTRALHBA: 7HBD: 3
#RO5 Violations: HBA (Lipinski): 9HBD (Lipinski): 3#RO5 Violations (Lipinski):
CX Acidic pKa: 11.99CX Basic pKa: 7.84CX LogP: 3.31CX LogD: 2.74
Aromatic Rings: 3Heavy Atoms: 33QED Weighted: 0.56Np Likeness Score: -1.33

References

1. Li Z,Powell CE,Groendyke BJ,Gero TW,Feru F,Feutrill J,Chen B,Li B,Szabo H,Gray NS,Scott DA.  (2020)  Discovery of a series of benzopyrimidodiazepinone TNK2 inhibitors via scaffold morphing.,  30  (19): [PMID:32739400] [10.1016/j.bmcl.2020.127456]

Source